Search results

Skip to results

Area of interest

Area of interest

Type

Type

Status

Status

Last updated

Last updated

Guidance programme

Advice programme

Showing 7636 to 7650 of 8314 results

  1. Ambu aScope4 Broncho for use in unexpected difficult airways (MTG14)

    We have moved medical technologies guidance 14 to become HealthTech guidance 312. This is to better reflect the NICE HealthTech programme which combines the former NICE Diagnostics Assessment programme, Interventional Procedures programme and Medical Technologies Evaluation programme and to help you find relevant content more quickly. The guidance itself has not changed.

  2. Pipeline Flex embolisation device with Shield Technology for the treatment of complex intracranial aneurysms (MTG10)

    We have moved medical technologies guidance 10 to become HealthTech guidance 287. This is to better reflect the NICE HealthTech programme which combines the former NICE Diagnostics Assessment programme, Interventional Procedures programme and Medical Technologies Evaluation programme and to help you find relevant content more quickly. The guidance itself has not changed.

  3. EXOGEN ultrasound bone healing system for long bone fractures with non-union or delayed healing (MTG12)

    We have moved medical technologies guidance 12 to become HealthTech guidance 296. This is to better reflect the NICE HealthTech programme which combines the former NICE Diagnostics Assessment programme, Interventional Procedures programme and Medical Technologies Evaluation programme and to help you find relevant content more quickly. The guidance itself has not changed.

  4. The Debrisoft monofilament debridement pad for use in acute or chronic wounds (MTG17)

    We have moved Medical technologies guidance 17 to become HealthTech guidance 334. This is to better reflect the NICE HealthTech programme which combines the former NICE Diagnostics Assessment programme, Interventional Procedures programme and Medical Technologies Evaluation programme and to help you find relevant content more quickly. The guidance itself has not changed.

  5. E‑vita open plus for treating complex aneurysms and dissections of the thoracic aorta (MTG16)

    We have moved Medical technologies guidance 16 to become HealthTech guidance 326. This is to better reflect the NICE HealthTech programme which combines the former NICE Diagnostics Assessment programme, Interventional Procedures programme and Medical Technologies Evaluation programme and to help you find relevant content more quickly. The guidance itself has not changed.

  6. moorLDI2-BI: a laser doppler blood flow imager for burn wound assessment (MTG2)

    We have moved medical technologies guidance 2 to become HealthTech guidance 257. This is to better reflect the NICE HealthTech programme which combines the former NICE Diagnostics Assessment programme, Interventional Procedures programme and Medical Technologies Evaluation programme and to help you find relevant content more quickly. The guidance itself has not changed.

  7. The geko device for reducing the risk of venous thromboembolism (MTG19)

    We have moved Medical technologies guidance 19 to become HealthTech guidance 344. This is to better reflect the NICE HealthTech programme which combines the former NICE Diagnostics Assessment programme, Interventional Procedures programme and Medical Technologies Evaluation programme and to help you find relevant content more quickly. The guidance itself has not changed.

  8. Parafricta Bootees and Undergarments to reduce skin breakdown in people with or at risk of pressure ulcers (MTG20)

    We have moved Medical technologies guidance 20 to become HealthTech guidance 355. This is to better reflect the NICE HealthTech programme which combines the former NICE Diagnostics Assessment programme, Interventional Procedures programme and Medical Technologies Evaluation programme and to help you find relevant content more quickly. The guidance itself has not changed.

  9. The ReCell Spray‑On Skin system for treating skin loss, scarring and depigmentation after burn injury (MTG21)

    We have moved Medical technologies guidance 21 to become HealthTech guidance 356. This is to better reflect the NICE HealthTech programme which combines the former NICE Diagnostics Assessment programme, Interventional Procedures programme and Medical Technologies Evaluation programme and to help you find relevant content more quickly. The guidance itself has not changed.

  10. The TURis system for transurethral resection of the prostate (MTG23)

    This guidance has been updated and replaced by NICE healthtech guidance 563.

  11. VibraTip for testing vibration perception to detect diabetic peripheral neuropathy (MTG22)

    We have moved Medical technologies guidance 22 to become HealthTech guidance 362. This is to better reflect the NICE HealthTech programme which combines the former NICE Diagnostics Assessment programme, Interventional Procedures programme and Medical Technologies Evaluation programme and to help you find relevant content more quickly. The guidance itself has not changed.

  12. UroLift for treating lower urinary tract symptoms of benign prostatic hyperplasia (MTG26)

    This guidance has been updated and replaced by NICE healthtech guidance 578.

  13. Tegaderm CHG securement dressing for vascular access sites in critically ill adults (MTG25)

    We have moved Medical technologies guidance 25 to become HealthTech guidance 379. This is to better reflect the NICE HealthTech programme which combines the former NICE Diagnostics Assessment programme, Interventional Procedures programme and Medical Technologies Evaluation programme and to help you find relevant content more quickly. The guidance itself has not changed.

  14. The Sherlock 3CG Tip Confirmation System for placement of peripherally inserted central catheters (MTG24)

    We have moved Medical technologies guidance 24 to become HealthTech guidance 368. This is to better reflect the NICE HealthTech programme which combines the former NICE Diagnostics Assessment programme, Interventional Procedures programme and Medical Technologies Evaluation programme and to help you find relevant content more quickly. The guidance itself has not changed.

  15. GreenLight XPS for treating benign prostatic hyperplasia (MTG29)

    This guidance has been updated and replaced by NICE healthtech guidance 650.